scholarly journals Incidence of pressure injury in an oncological intensive care unit

2019 ◽  
Vol 72 (6) ◽  
pp. 1490-1495
Author(s):  
Rafael Tavares Jomar ◽  
Rubens Pelágio de Jesus ◽  
Marcos Pelágio de Jesus ◽  
Bárbara Rocha Gouveia ◽  
Eriane Nascimento Pinto ◽  
...  

ABSTRACT Objective: to investigate the incidence of pressure injury in cancer patients of an intensive care unit. Method: A longitudinal study with 105 patients admitted to an oncological intensive care unit. The incidence rate was calculated as the number of events per 100 patient-days. Cumulative incidence was calculated both globally and according to selected characteristics, and submitted to hypothesis tests. Results: incidence rate per 100 patient-days was 1.32, and global cumulative incidence was 29.5%. A higher incidence was observed in patients with chronic diseases who had at least one episode of diarrhea, received enteral nutrition, and took vasoactive or sedative drugs for a prolonged period of time. Regarding type of tumour and antineoplastic treatments, no differences in incidence were observed. Conclusion: A high cumulative global incidence of pressure lesion was reported in cancer patients admitted to the intensive care unit, although tumour characteristics and antineoplastic treatments did not affect incidence.

Pharmacy ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 121
Author(s):  
Roland N. Dickerson ◽  
Christopher T. Buckley

Propofol, a commonly used sedative in the intensive care unit, is formulated in a 10% lipid emulsion that contributes 1.1 kcals per mL. As a result, propofol can significantly contribute to caloric intake and can potentially result in complications of overfeeding for patients who receive concurrent enteral or parenteral nutrition therapy. In order to avoid potential overfeeding, some clinicians have empirically decreased the infusion rate of the nutrition therapy, which also may have detrimental effects since protein intake may be inadequate. The purpose of this review is to examine the current literature regarding these issues and provide some practical suggestions on how to restrict caloric intake to avoid overfeeding and simultaneously enhance protein intake for patients who receive either parenteral or enteral nutrition for those patients receiving concurrent propofol therapy.


2016 ◽  
Vol 27 ◽  
pp. ix174
Author(s):  
A.J. Sunggoro ◽  
A. Arifin ◽  
S. Marwanta ◽  
S.M. Atmodjo ◽  
S. Maryono

Nursing Open ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 224-231
Author(s):  
Brita F. Olsen ◽  
Berit T. Valeberg ◽  
Morten Jacobsen ◽  
Milada C. Småstuen ◽  
Kathleen Puntillo ◽  
...  

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S159
Author(s):  
J. Maniate ◽  
S. Sharma ◽  
S. Navaratnam

Sign in / Sign up

Export Citation Format

Share Document